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Abstract
Background: Transfusion transmissible infections, such as HIV, HBV, HCV and syphilis are on the rise and pose a threat 
to blood safety.
Objective: To determine prevalence and demographic profiles of  TTI’s among first time blood donors in Abeokuta, Nige-
ria.
Methods: The study was conducted between February to November 2013; 130 first time blood donors were tested for the 
presence of  HIV, HBsAg, HCV antibodies and Treponema palidium antibodies using EIA based rapid immunochromato-
graphic kits. Data analysis was done using SPSS with a level of  significance of  p<0.05. 
Results: Prevalence rates to HIV, HBsAg, HCV antibody, were 6.2% (n=8), 10% (n=13) and 1.5% (n=2), there was 0% 
prevalence to Treponema palidium antibodies. Group specific prevalence rates revealed that educational status was associ-
ated with HBsAg positivity (p = 0.028), donors with a history of  previous blood transfusion was also statistically associated 
with HIV sero-reactivity (p = 0.013).
Conclusions: High levels of  HBsAg  and HIV were observed, there is need to revise the donor testing algorithm in Nigeria 
in line with the prevalence of  TTI’s. We also advocate that a National surveillance system for TTI’s be established through 
our National blood transfusion service (NBTS) program, a second serological test is also suggested to reduce the risk of  
occult HBV infection in Nigeria.
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Blood transfusion remains one of  the most important 
therapeutic options in life threatening disease condi-
tions and also in sustaining life after severe blood loss 
1. In Nigeria, demand for blood transfusion has been 
reported to be high as a result of  frequent road traffic 
accidents, surgical and obstetric blood loss, as well as 
anemia from other sources2. Transfusion transmissi-
ble infections (TTI’s), principally HIV 1&2, Hepatitis 
B and C viruses (HBV and HCV) as well as Syphilis, 
have continued to raise concerns about blood safety as 
a result of  the risk of  infection. Sub-Saharan Africa re-
mains one of  the highest regions with these infections, 
with 68% of  about 38 million HIV infected people re-
siding in this, region3, while for almost 18 years the Cen-
tral African region remained the highest HCV prevalent 
region worldwide4.
In Nigeria the main sources of  blood for transfusion are 
commercial blood donors, replacement and  voluntary 
blood  donors1.  Commercial blood  donors  are  usually 
contracted to give blood to intending recipients for a 
negotiated fee. Replacement donors are mostly family 
members or close friends of  the patient donating blood 
for use by the patient or inmost cases after transfusion 
under emergency cases. Voluntary donors are Nigeri-
ans who without any inducement donate blood to an 
unknown patient on companionate ground. Voluntary 
donors have been reported to be the safest group of  
donors because they tend to have better health seek-
ing behavior than commercial blood donors2. The Ni-
gerian government in trying to meet WHO set goals 
of  100% voluntary blood donation by 20205,6, the Na-
tional Blood transfusion service (NBTS) was official-
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ly launched in the 6 geo-political zones in 20001. Ever 
since then the Federal Ministry of  health (FMoH) has 
continued to review the NBTS policy and expand its 
activities. Currently there is a National Algorithm for 
donor screening for TTI’s but despite all this effort, the 
risk of  exposure to TTI’s still remains7, 8. 
There is urgent need to revise donor recruitment pro-
tocols as well as establish a blood  safety surveillance 
system. The  objective of   this  study was  to  determine 
the prevalence and demographic profile of  HIV, HBV, 
HCV and Syphilis among first time blood donors in 
Abeokuta, Nigeria.
Material and Methods
Study Area and study population: The study was 
conducted at Abeokuta capital city of  Ogun state south 
west, Nigeria. It is located east of  the Ogun river, coor-
dinates are 3020E. 7o9N. the city is 217ft above sea level 
and has a population of  over 1 million inhabitants9. The 
study site is the Blood transfusion Unit of  the Federal 
Medical centre Idi-aba, Abeokuta. It  is  the main  re-
ferral Hospital in  Ogun state serving the  blood trans-
fusion need of  patients from around Ogun State and 
environs receiving treatment at the Hospital.
Study design: The study was a prospective analysis of  
blood transfusion transmissible infections among first 
time blood donors. It is part of  the Blood transfusion 
unit blood procurement and transfusion surveillance 
program at Federal Medical center, Abeokuta, Nigeria. 
Study participants were drawn from both replacement 
donors and voluntary donors,  consecutive  sampling 
method  was  adopted.  The  study  was  done  between 
February 2013 to November 2013. Recruitment criteria 
include, no previous history of  blood  donation, age  of  
18  to  60,  and  packed  cell  volume  of   38%  and  above. 
All participants were counseled before consenting to 
partake after which they filled the consent and Donor 
information form. Tests that were done include blood 
grouping, HIV1&2 screening, HBsAg, anti- HCV, and 
Syphilis Ultra Rapid test (Qualitative detection of  IgG 
and IgM antibodies to Treponema palidium antigens).
Serological testing: About 5mls of  blood was drawn 
into anticoagulant bottle (EDTA) through venepunture. 
Testing was done for HIV 1&2 using a double parallel 
rapid kit, Determine® (Abbot Labs Inc USA) and Stat-
Pak® Chembio. Test protocol and result interpretation 
was done according to the manufacturer instruction. 
HBsAg and HCV screening was done using immuno-
chromatographic rapid kits by Diaspot® (Djarkarta,In-
donesia). Screening for Treponema palidium (Spyhilis) 
Antibodies was done Using ABON® Syphis Ultra Rap-
id Test strip (Abon Biopharm, Hangzhou Co, P.R. Chi-
na). 
Statistical analysis: Data analysis was conducted using 
the statistical software SPSS Vs 15 for Windows (SPSS 
Inc.Chicago IL). The chi square test was used to test for 
significance between variables, a value of  p<0.05 was 
considered as significant.
Results:
During the study period a total of  130 first time blood 
donors were screened age range 20 to 57 years, mean 
age 32 ± 8 yrs, median age 38. Majority of  recruited 
donors were male 126(96.9%), other  demographic var-
iables  such  as  marital  status  was  almost  evenly dis-
tributed (Table 1). 
With regards to previous blood transfusions, 89.2% 
of  recruited donors have never been transfused while 
10.8% of  recruited donors have been transfused at 
least once. With respect to individual tests carried out, 
8(6.2%) were HIV positive donors, 13(10%) were pos-
Table  1:  Demographic  distribution,  among  first  time  blood  donors  at  FMC, Abeokuta, Nigeria 
2013.
itive for HBsAg while 2(1.5%) were positive for an-
ti-HCV. There  was  zero  reactivity  to  Treponema 
palidium  antibodies  among  the  tested participants; 
there was no dual positivity recorded.














P value X2 
Sex       
Male 8(6.3%) 118(93.7%) P > 0.05 12(9.5%) 114(90.5%) P > 0.05 
Female 0(0%) 4(100%)  0(0%) 4(100%)  
Age       
< 29 3(6.5%) 43(93.5%) P > 0.05 2(4.3%) 44(95.7%) P > 0,05 
30-40 5(7.8%) 59(92.2%)  4(12.1%) 58(87.9%)  
> 40 0(0%) 18(100%)  2(11.1%) 16(88.9%)  
Marital       
Status       
Married 5(7.1%) 65(92.9%) P > 0.05 8(11.1%) 64(88.9%) P > 0.05 
Single 3(5.2%) 65(94.8%)  4(9.6%) 54(93.1%)  
Edu       
Status       
Secd sch 3(5.2%) 55(94.8%) P > 0.05 4(6.9%) 54(93.1%) P > 0.05 
Graduate 2(4.8%) 40(95.2%)  4(9.5%) 38(90.5%)  
Illiterate 3(16.7%) 15(83.3%)  4(22.2%) 14(77.8%)  
Prev BT       
Never 6(5.1%) 112(94.9%) P = 0.013* 10(8.6%) 106(91.4%) P > 0.05 
≥ 1 4(33.3%) 8(66.7%)  2(14.3%) 12(85.7%)  
 
Key * = Significant value (P < 0.05, Chi square test), X2 = Chi square test 
Secd sch = secondary education, Prev BT = Previous receipt of blood transfusion.
Table 2 shows the various seroprevalence rates of  in-
dividual Transfusion transmissible infectious markers, 
HIV and HBsAg in relation to various categorical var-
iables. Age range 30-40 recorded the highest preva-
lence 7.8% for HIV and 12.1% for HBsAg. Prevalence 
was  higher  among  married  than  single  participants. 
The  illiterate  group recorded the highest prevalence 
for both HIV and HBsAg seropositivity. All analyzed 
variables did not show any statistically significant asso-
ciation with seropositivity for any of  the analyzed TTI 
markers p > 0.05. Previous blood transfusion and HIV 
seropositivity, showed significant association, p=0.013, 
among first time blood donors, in FMC, Abeokuta. 
There was zero prevalence rate recorded for Syphilis 
antibodies (Treponema palladium), therefore no entry 
was recorded for anti-Syphilis antibody rate in our re-



























Key: * = Significant value, Secd sch = secondary education, Prev BT = Previous receipt 
of blood transfusion








P value X2 
Sex    
Males 2(1.6%) 124(98.4%) P > 0.05 
Females 0(0%) 4(100%)  
Age    
< 29 0(0%) 46(100%) P > 0.05 
30-40 2(3%) 64(97%)  
> 40 0(0%) 18(100%)  
Marital    
Status    
Married 2(2.8%) 70(97.2%) P > 0.05 
Single 0(0%) 58(100%)  
Edu Status    
Secd sch 0(0%) 58(100%) P = 0.028* 
Graduate 0(0%) 42(100%)  
Illiterate 2(11.1%) 16(88.9%)  
Prev BT    
Never 2(1.7%) 114(98.3%) P > 0.05 
≥ 1 0(0%) 14(100%)  
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Results in table 3 show the distribution of  analyzed 
variables in relation to prevalence of  HCV antibodies 
among first time blood donors in Abeokuta. A similar 
trend with HIV prevalence was observed in relation to 
category based HCV antibody prevalence. Educational 
status was statistically associated with HIV prevalence, 
only 2 of  male donors were positive for HCV antibody.
Discussion
We recorded an overall prevalence of  6.2% for HIV 
(Figure 1, shows pie chart with
approx 6% HIV prevalence), this is higher than the esti-
mated prevalence of  HIV of  1.7% among HCT subjects 
in Abeokuta (Ogun SACA 2014, unpublished data).It is 
also higher than the estimated national HIV prevalence 
rate put at about 4%2. Our report of  6.2% is lower 
than that of  a recent study done in the same study site, 
which recorded 11.7% among hospital attendees 10. It 
is also lower than that of  a similar study done at Benin, 
South-south, Nigeria which reported 7.2% prevalence2. 
Our report of  6.2% is however relatively high consid-
ering the fact that blood donors represent the healthy 
population group in any community. This points to the 
fact that HIV is still being actively transmitted among 
the most productive age bracket in our community. An 
overall HBsAg prevalence rate of  10% was recorded in 
our current study (Figure 1), 
Fig 1: Prevalence of  serological markers for TTIs, HIV, HBsAg and HCV antibody among first time 
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this is much higher than a similar study done at Lagos, 
which recorded 4.7%2 our results were much higher 
than a report of  a similar study done at Yola, Nige-
ria 2.4% 11. Some previous reports were higher than 
ours for instance, a study done at Ibadan Nigeria by 
Fashola et al 12 reported a prevalence rate of  13.2%, 
another study done in the South-south region of  Ni-
geria reported 10.6%13, a prevalence rate of  8.3% in 
Tanzanian donors 14. In Another study in Burkina Faso, 
HBV was the most prevalent TTI (13.4%) of  donors 
screened15. Other similar studies from other parts of  
sub-Saharan Africa have given similar high prevalence 
of  HBV among blood donors for instance in South Su-
dan, 6.25% HBV prevalence was reported16. In Eritrea, 
data from their National blood transfusion service is 
also in agreement with our current report17. The reports 
of  our study, reaffirms endemicity of  HBV infection 
in sub-saharan, African communities8. Prevalence rate 
of  anti-HCV antibodies among our study participants 
stood at 1.5%(n=2), this is in accordance with previ-
ous reports of  low seroprevalence of  HCV in various 
parts of  Nigeria, 0.2% (2), 2.4%11. Figure 1 shows the 
overall distribution of  TTI serological markers, approx-
imated to the nearest whole number, from fig 1, about 
82% of  first time donors tested negative to all the TTI’s 
There was no reactivity to Treponema palidium anti-
bodies, among our study participants, the low rates of  
sero- reactivity to Treponema palidium antibodies has 
been previously reported among pregnant women in 
Abeokuta18. The low prevalence can be attributed to 
increased awareness against STI and availability and af-
fordability of  effective antibiotics (Nwadike Personal 
communication). Similar trend as our current study has 
also been reported from countries with higher preva-
lence of  HBV, such as, India19,20, and China21. There was 
no dual positivity among the tested donors.
Results from analysis of  category based prevalence rates 
to individual TTI serological markers, revealed that 
only male gender recorded positive results, with 6.3% 
prevalence for HIV, 9.5% HBsAg prevalence and 1.4% 
HCV, there was no significant association of  any of  the 
TTI in relation to gender. Seroprevalence rates of  TTI 
markers in relation to age range distribution revealed 
that age range 30-40, had the highest rate, with HIV 
recording 7.8%, HBsAg 12.1% and HCV 3%. An inter-
esting finding was that age range 29 and below recorded 
a lesser prevalence for HIV and HCV antibodies than 
other age groups; this is an indication of  success on the 
part of  Government agencies and Non-governmental 
organizations in the fight against new HIV infections. 
This is encouraging as previous studies have indicated 
that the adolescent age group is the driving force of  
new HIV infections in Nigeria22,23. Prevalence of  TTI 
markers in relation to marital status was not statistically 
significant (p > 0.05), for all the tested TTI markers, 
although married donors recorded a higher prevalence 
for HIV, HBsAg and HCV antibody. This is an indi-
cation that more effort needs to be channeled toward 
family oriented prevention strategies for blood borne 
infections, as well as increase advocacy toward women 
empowerment on reproductive health issues. Results 
of  TTI prevalence rate according to educational status 
shows a statically significant association between HCV 
antibody prevalence and educational status (P = 0.028). 
Illiterate donors recorded the highest prevalence of  
11.1% for HCV, 16.7% for HIV and 26.5% for HBsAg. 
Our result is in accordance to a recent study done in the 
same study location that reported significant associa-
tion of  HBsAg positivity with educational status8. This 
finding has been attributed to better health promotion 
practices and health seeking behavior amongst the 
educated8. Data generated also showed that previous 
history of  blood transfusion among intending donors 
was statistically associated with HIV antibody positivity 
(P=0.013). This is expected as unsafe blood transfusion 
remains one of  the major routes of  HIV transmission 
in Nigeria24. A limitation to our study was our inability 
to consistently identify voluntary first time blood do-
nors among our study group, this is however regretted. 
Based on our current finding we suggest a revision of  
donor screening test algorithm based on the currently 
observed prevalence. More research investigating actual 
National prevalence is however required.
Conclusion
From our current study, HBV recorded the highest 
prevalence rate among blood donors, followed by HIV 
and HCV, with Treponema palidium (Syphilis) record-
ing zero prevalence. This reaffirms the endemicity of  
HBV infections in Nigeria. HIV prevalence remains on 
the high side and new HIV transmission seems to con-
tinue, despite increased effort toward zero transmission 
rates as advocated by WHO25.
We recommend that a more efficient and robust test-
ing algorithm be developed, with the most prevalent 
TTI, HBV, leading the series of  test, followed by HIV, 
HCV and lastly Syphilis. The algorithm should be in 
such a manner as to exclude each infection according 
to their general prevalence. This will reduce cost of  
testing, turn around time and improve efficiency in a 
resource challenged setting such as ours. We also ad-
vocate that a National surveillance program against 
TTI be set up through the National Blood transfusion 
service (NBTS). The resultant data generated would be 
useful in updating policy regulation on donor testing in 
Nigeria. We also suggest the inclusion of  a second se-
rological test to exclude occult HBV infection. This can 
be either anti-HBc or HBeAg along side HBsAg test, to 
reduce the risk of  accidental HBV infection in HBsAg 
negative blood donors, a possibility that has been previ-
ously reported in Nigeria26,7.
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